SciVision Biotech Inc. (TPE:1786)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Adjustment and Elimination	-32.56M	-17.35M	-	-	-
Beauty Management Service Department	66.92M	19.43M	-	-	-
Beauty Management Service Department Growth	244.41%	-	-	-	-
Medical Device Manufacturing Department	852.27M	881.23M	-	-	-
Medical Device Manufacturing Department Growth	-3.29%	-	-	-	-
Manufacture and Sale of Hyaluronic Acid Products	-	-	712.99M	557.35M	505.54M
Manufacture and Sale of Hyaluronic Acid Products Growth	-	-	27.93%	10.25%	8.28%
Total	886.62M	883.31M	712.99M	557.35M	505.54M
Total Growth	0.37%	23.89%	27.93%	10.25%	8.28%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Asia	589.41M	662.89M	549.64M	419.16M	443.06M
Asia Growth	-11.09%	20.60%	31.13%	-5.39%	-
Europe	279.98M	208.12M	153.15M	131.09M	58.76M
Europe Growth	34.53%	35.89%	16.83%	123.08%	-
America	17.24M	12.29M	10.19M	7.10M	3.72M
America Growth	40.19%	20.64%	43.60%	90.73%	-
Total	886.62M	883.31M	712.99M	557.35M	505.54M
Total Growth	0.37%	23.89%	27.93%	10.25%	8.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error